Vanguard Fiduciary Trust
NXL icon

Vanguard Fiduciary Trust’s Nexalin Technology NXL Stock Holding History

Vanguard Fiduciary Trust’s Portfolio NXL Stock Details NXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17K Hold
51,386
– – ﹤0.01% 4011
2026
Q1 		$17.9K Buy
+51,386
New +$26.8K ﹤0.01% 3965

Other funds holding NXL

PEAK6
PEAK6 Chicago, Illinois $48.6B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Vanguard Fiduciary Trust's NXL Position: Q2 2026 in Review

Vanguard Fiduciary Trust held its Nexalin Technology (NXL) position steady in Q2 2026 at 51,386 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #4011.

Vanguard Fiduciary Trust first reported a position in NXL in Q1 2026 and has held it in 2 quarters since. The position peaked at $17.9K in Q1 2026. 21 funds tracked by Wall St. Rank hold NXL as of Q2 2026.

  • Vanguard Fiduciary Trust held 51,386 shares of Nexalin Technology worth $17K as of Q2 2026.
  • Vanguard Fiduciary Trust left its Nexalin Technology share count unchanged in Q2 2026.
  • Nexalin Technology made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #4011 holding.
  • Vanguard Fiduciary Trust first reported a position in Nexalin Technology in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Nexalin Technology position peaked at $17.9K in Q1 2026.
  • 21 funds tracked by Wall St. Rank held Nexalin Technology as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.